AXIM Biotechnologies

AXIM Biotechnologies, Inc. is a research and development company headquartered in San Diego, California, focused on advancing diagnostics and treatments for oncology and infectious diseases, including COVID-19. The company has developed NeuCovix, a rapid diagnostic test designed to measure levels of functional neutralizing antibodies that may prevent SARS-CoV-2 from entering host cells. In addition to its work in infectious diseases, AXIM Biotechnologies is also engaged in creating rapid diagnostic tests for early cancer detection and developing proprietary small molecule drugs aimed at treating cancer and inhibiting metastasis. Founded in 2010, the company is committed to innovation in biotechnology and maintains a diverse portfolio that includes pharmaceutical, nutraceutical, and cosmetic products.